Intrinsic K-Ras dynamics: A novel molecular dynamics data analysis method shows causality between residue pair motions

K-Ras is the most frequently mutated oncogene in human cancers, but there are still no drugs that directly target it in the clinic. Recent studies utilizing dynamics information show promising results for selectively targeting mutant K-Ras. However, despite extensive characterization, the mechanisms by which K-Ras residue fluctuations transfer allosteric regulatory information remain unknown. Understanding the direction of information flow can provide new mechanistic insights for K-Ras targeting. Here, we present a novel approach –conditional time-delayed correlations (CTC) – using the motions of all residue pairs of a protein to predict directionality in the allosteric regulation of the protein fluctuations. Analyzing nucleotide-dependent intrinsic K-Ras motions with the new approach yields predictions that agree with the literature, showing that GTP-binding stabilizes K-Ras motions and leads to residue correlations with relatively long characteristic decay times. Furthermore, our study is the first to identify driver-follower relationships in correlated motions of K-Ras residue pairs, revealing the direction of information flow during allosteric modulation of its nucleotide-dependent intrinsic activity: active K-Ras Switch-II region motions drive Switch-I region motions, while α-helix-3L7 motions control both. Our results provide novel insights for strategies that directly target mutant K-Ras.

[1]  Ruth Nussinov,et al.  The disordered hypervariable region and the folded catalytic domain of oncogenic K-Ras4B partner in phospholipid binding. , 2016, Current opinion in structural biology.

[2]  B. Erman Effects of ligand binding upon flexibility of proteins , 2015, Proteins.

[3]  Igor N. Berezovsky,et al.  Structure-Based Statistical Mechanical Model Accounts for the Causality and Energetics of Allosteric Communication , 2016, PLoS Comput. Biol..

[4]  P. Kollman,et al.  A well-behaved electrostatic potential-based method using charge restraints for deriving atomic char , 1993 .

[5]  V. Hilser,et al.  The ensemble nature of allostery , 2014, Nature.

[6]  Yi Liu,et al.  Selective Inhibition of Oncogenic KRAS Output with Small Molecules Targeting the Inactive State. , 2016, Cancer discovery.

[7]  Alex Travesset,et al.  Differential dynamics of RAS isoforms in GDP‐ and GTP‐bound states , 2015, Proteins.

[8]  V. Hornak,et al.  Comparison of multiple Amber force fields and development of improved protein backbone parameters , 2006, Proteins.

[9]  R. Nussinov,et al.  Mechanisms of Membrane Binding of Small GTPase K-Ras4B Farnesylated Hypervariable Region* , 2015, The Journal of Biological Chemistry.

[10]  Takashi Kumasaka,et al.  Structural Basis for Conformational Dynamics of GTP-bound Ras Protein* , 2010, The Journal of Biological Chemistry.

[11]  Simon Scheuring,et al.  Mechanics of proteins with a focus on atomic force microscopy , 2013, Journal of Nanobiotechnology.

[12]  Piotr Cieplak,et al.  The R.E.D. tools: advances in RESP and ESP charge derivation and force field library building. , 2010, Physical chemistry chemical physics : PCCP.

[13]  Hans Robert Kalbitzer,et al.  Conformational States of Human Rat Sarcoma (Ras) Protein Complexed with Its Natural Ligand GTP and Their Role for Effector Interaction and GTP Hydrolysis* , 2010, The Journal of Biological Chemistry.

[14]  C. Granger Investigating causal relations by econometric models and cross-spectral methods , 1969 .

[15]  J. K. Cheong,et al.  The renewed battle against RAS-mutant cancers , 2016, Cellular and Molecular Life Sciences.

[16]  C. Mattos,et al.  DRoP: a water analysis program identifies Ras-GTP-specific pathway of communication between membrane-interacting regions and the active site. , 2014, Journal of molecular biology.

[17]  Taebo Sim,et al.  Therapeutic targeting of oncogenic K-Ras by a covalent catalytic site inhibitor. , 2014, Angewandte Chemie.

[18]  Priyanka Prakash,et al.  The Role of Conserved Waters in Conformational Transitions of Q61H K-ras , 2012, PLoS Comput. Biol..

[19]  J Andrew McCammon,et al.  A novel switch region regulates H‐ras membrane orientation and signal output , 2008, The EMBO journal.

[20]  Thorsten Graf,et al.  Stabilizing a weak binding state for effectors in the human ras protein by cyclen complexes. , 2010, Angewandte Chemie.

[21]  J Andrew McCammon,et al.  Mapping the nucleotide and isoform-dependent structural and dynamical features of Ras proteins. , 2008, Structure.

[22]  J Andrew McCammon,et al.  Conformational selection in G-proteins: lessons from Ras and Rho. , 2010, Biophysical journal.

[23]  E D Laue,et al.  Regional polysterism in the GTP-bound form of the human c-Ha-Ras protein. , 1997, Biochemistry.

[24]  Jenn-Kang Hwang,et al.  Computational Analysis of KRAS Mutations: Implications for Different Effects on the KRAS p.G12D and p.G13D Mutations , 2013, PloS one.

[25]  Piotr Cieplak,et al.  R.E.D. Server: a web service for deriving RESP and ESP charges and building force field libraries for new molecules and molecular fragments , 2011, Nucleic Acids Res..

[26]  H. Kalbitzer,et al.  A novel mechanism for the modulation of the Ras-effector interaction by small molecules. , 2005, Biochemical and biophysical research communications.

[27]  D. Kern,et al.  The role of dynamics in allosteric regulation. , 2003, Current opinion in structural biology.

[28]  Frank Noé,et al.  Automated computation of low‐energy pathways for complex rearrangements in proteins: Application to the conformational switch of Ras p21 , 2005, Proteins.

[29]  I. Bahar,et al.  Gaussian Dynamics of Folded Proteins , 1997 .

[30]  Ruth Nussinov,et al.  GTP Binding and Oncogenic Mutations May Attenuate Hypervariable Region (HVR)-Catalytic Domain Interactions in Small GTPase K-Ras4B, Exposing the Effector Binding Site* , 2015, The Journal of Biological Chemistry.

[31]  On the dynamic origins of allosteric activation. , 2001 .

[32]  Ozlem Keskin,et al.  GTP-Dependent K-Ras Dimerization. , 2015, Structure.

[33]  Y. Engelborghs,et al.  Molecular dynamics simulation of the solution structures of Ha-ras-p21 GDP and GTP complexes: flexibility, possible hinges, and levers of the conformational transition. , 1995, Biochemistry.

[34]  Sheng Li,et al.  Phosphorylation-induced Conformational Changes in Rap1b , 2009, The Journal of Biological Chemistry.

[35]  G. Zaccai,et al.  How soft is a protein? A protein dynamics force constant measured by neutron scattering. , 2000, Science.

[36]  Ruth Nussinov,et al.  Mapping the Conformation Space of Wildtype and Mutant H-Ras with a Memetic, Cellular, and Multiscale Evolutionary Algorithm , 2015, PLoS Comput. Biol..

[37]  Priyanka Prakash,et al.  Lessons from computer simulations of Ras proteins in solution and in membrane. , 2013, Biochimica et biophysica acta.

[38]  Kevan M. Shokat,et al.  K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions , 2013, Nature.

[39]  D. Longo,et al.  Improving Prospects for Targeting RAS. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[40]  H. Varmus,et al.  KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib , 2005, PLoS medicine.

[41]  D. Esposito,et al.  Dragging ras back in the ring. , 2014, Cancer cell.

[42]  Junmei Wang,et al.  Development and testing of a general amber force field , 2004, J. Comput. Chem..

[43]  A. Lièvre,et al.  KRAS mutation status is predictive of response to cetuximab therapy in colorectal cancer. , 2006, Cancer research.

[44]  Suryani Lukman,et al.  The Distinct Conformational Dynamics of K-Ras and H-Ras A59G , 2010, PLoS Comput. Biol..

[45]  M. Buck,et al.  Combining NMR and molecular dynamics studies for insights into the allostery of small GTPase-protein interactions. , 2012, Methods in molecular biology.

[46]  L. Perkins,et al.  Ras oncoprotein inhibitors: the discovery of potent, ras nucleotide exchange inhibitors and the structural determination of a drug-protein complex. , 1997, Bioorganic & medicinal chemistry.

[47]  Ruth Nussinov,et al.  The higher level of complexity of K‐Ras4B activation at the membrane , 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[48]  Schreiber,et al.  Measuring information transfer , 2000, Physical review letters.

[49]  A. Gorfe,et al.  Ras membrane orientation and nanodomain localization generate isoform diversity , 2010, Proceedings of the National Academy of Sciences.

[50]  Ruth Nussinov,et al.  Drugging Ras GTPase: a comprehensive mechanistic and signaling structural view. , 2016, Chemical Society reviews.

[51]  Norbert Perrimon,et al.  Direct inhibition of oncogenic KRAS by hydrocarbon-stapled SOS1 helices , 2015, Proceedings of the National Academy of Sciences.

[52]  James Andrew McCammon,et al.  Ras Conformational Switching: Simulating Nucleotide-Dependent Conformational Transitions with Accelerated Molecular Dynamics , 2009, PLoS Comput. Biol..

[53]  I. Vetter,et al.  The Guanine Nucleotide-Binding Switch in Three Dimensions , 2001, Science.

[54]  Kendra Marcus,et al.  Direct Attack on RAS: Intramolecular Communication and Mutation-Specific Effects , 2015, Clinical Cancer Research.

[55]  Priyanka Prakash,et al.  Binding hotspots on K‐ras: Consensus ligand binding sites and other reactive regions from probe‐based molecular dynamics analysis , 2015, Proteins.

[56]  N. Goodey,et al.  Allosteric regulation and catalysis emerge via a common route. , 2008, Nature chemical biology.

[57]  J. Howard,et al.  Mechanics of Motor Proteins and the Cytoskeleton , 2001 .

[58]  Neal Rosen,et al.  Allele-specific inhibitors inactivate mutant KRAS G12C by a trapping mechanism , 2016, Science.

[59]  H. Kamberaj,et al.  Extracting the causality of correlated motions from molecular dynamics simulations. , 2009, Biophysical journal.

[60]  C. Mattos,et al.  Allosteric modulation of Ras positions Q61 for a direct role in catalysis , 2010, Proceedings of the National Academy of Sciences.

[61]  Mingming Jia,et al.  COSMIC: exploring the world's knowledge of somatic mutations in human cancer , 2014, Nucleic Acids Res..

[62]  Harrison J. Hocker,et al.  Novel Allosteric Sites on Ras for Lead Generation , 2011, PloS one.

[63]  J. Downward Targeting RAS signalling pathways in cancer therapy , 2003, Nature Reviews Cancer.

[64]  S. Rodenhuis,et al.  K-ras oncogene activation as a prognostic marker in adenocarcinoma of the lung. , 1990, The New England journal of medicine.

[65]  Francesca Fanelli,et al.  Nucleotide Binding Switches the Information Flow in Ras GTPases , 2011, PLoS Comput. Biol..

[66]  K Schulten,et al.  VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.

[67]  Dima Kozakov,et al.  Analysis of binding site hot spots on the surface of Ras GTPase. , 2011, Journal of molecular biology.

[68]  Laxmikant V. Kalé,et al.  Scalable molecular dynamics with NAMD , 2005, J. Comput. Chem..

[69]  Martin Karplus,et al.  The elastic properties of the structurally characterized myosin II S2 subdomain: a molecular dynamics and normal mode analysis. , 2008, Biophysical journal.